An analysis of whether sartans used in the treatment of hypertension could increase ACE2 expression and thus contribute to increasing the development of viral infection by allowing SARS-CoV-2 to more intensely enter vulnerable cells has also been conducted. The gene discussed is ACE2; the disease is viral infectious disease.